Features Screener Stocks Charts
Sign In Sign Up

Shilpa Medicare Limited Income Statement

NSE:SHILPAMED | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year SHILPAMED income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 11.52B 12.86B
Cost of Revenue -4.08B -4.10B
Gross Profit 7.44B 8.76B
Sales, General & Admin -2.81B -2.93B
Operating Income 1.37B 2.04B
Profit Before Tax 543.41M 1.22B
Net Income 318.74M 782.93M
Diluted Shares 173.60M 194.86M
Diluted EPS 1.84 4.02

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025